Pfizer Files Patent Suit In New Jersey Federal Court Over Proposed Generic
TRENTON, N.J. — Efforts by Dr. Reddy’s Laboratories Inc. (DRL) to develop and market a generic form of the breast cancer treatment drug “Ibrance” represent patent infringement, Pfizer Inc. asserts in...To view the full article, register now.
Already a subscriber? Click here to view full article